Whitepapers

This paper addresses the four clinical trial aspects Novella Clinical considers most critical for medical device developers seeking to enter the US market with implantable…
Read More...

The US healthcare system is in the midst of dramatic change — new technologies, new medications, and new techniques are revolutionizing how and where healthcare is delivered. At…
Read More...

The pressure to change is coming from all directions. Patients want care to be more personalized and convenient. Employees want the systems that support their work to function…
Read More...

At Cigna, we strive to help our customers get healthy and stay healthy. One vital way we achieve this goal is by identifying customer health and wealth opportunities and engaging…
Read More...

Since the United States (U.S.) Food and Drug Administration’s (FDA) approval of the first commercial systems in 2000, digital mammography has become an accepted standard of care…
Read More...

All statements of fact, opinion, or analysis expressed in ILIA white papers are those of the respective analysts.They do not necessarily reflect formal positions or views of ILIA.…
Read More...

Confronted with rising costs, staff shortages and complicated finances, healthcare providers are using technology to find efficiencies in administration and channel savings to…
Read More...

Historically, health systems have approached analytics primarily from an incremental, retrospective and operational-siloed approach. This approach, “Analytics 1.0,” has…
Read More...

This report sets out the key challenges, risks and opportunities associated with establishing a national medicinal cannabis scheme in Australia. The report is comprised of several…
Read More...

Massive changes are sweeping the health sciences business landscape and are dramatically impacting healthcare and life sciences organizations. The industry faces constant…
Read More...